Abstract
Targeted gene delivery is essential for gene therapy involving in vivo gene transfer. In the present study we analyzed the efficiency and tissue-specificity of gene transfer into the liver with recombinant adenoviruses. Adenovirus vectors carrying the E. coli lacZ gene (Ad.RSV.β-gal) and the firefly luciferase gene (AdCMV-luc) as reporters were administered to the liver of adult Wistar rats, either via infusion into the portal vein (intraportal infusion; IPI) or via perfusion of the vascularly isolated liver (isolated liver perfusion; ILP). Ex vivo liver perfusion experiments with Ad.RSV.β-gal were used to optimize the conditions for hepatic gene transfer. Ex vivo perfusion of rat livers with 2 × 109 plaque forming units (p.f.u.) Ad.RSV.β-gal was sufficient to infect about 20% of the liver parenchymal cells. Perfusion with chelating agents (1 mM EGTA, or 2 mM EDTA) prior to the administration of the vector increased the efficiency to at least 40%. Similar efficiencies were obtained in experiments with liver lobes of Rhesus monkeys. In vivo administration of AdCMV-luc via ILP resulted in a significantly more efficient (P = 0.028) and also more reproducible gene transfer when compared to IPI. Although detectable in both groups, extrahepatic luciferase expression was considerably reduced in the ILP group. Our data demonstrate that IPL can be used for efficient and reproducible liver-specific gene delivery. Therefore, we think that the perfusion of vascularly isolated organs is useful as a modality for the tissue-specific administration of recombinant adenovirus vectors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roos, W., Fallaux, F., Marinelli, A. et al. Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4, 55–62 (1997). https://doi.org/10.1038/sj.gt.3300362
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300362
Keywords
This article is cited by
-
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
Gene Therapy (2010)
-
Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy
Diabetologia (2007)
-
Impaired neutralising antibody formation and high transduction efficacy after isolated hepatic perfusion with adenoviral vectors
British Journal of Cancer (2004)
-
Adenovirus-mediated gene transfer of interferon α improves dimethylnitrosamine-induced liver cirrhosis in rat model
Gene Therapy (2003)
-
Creation of immune ‘stealth’ genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1
Gene Therapy (2003)